AAAAAA

   
Results: 1-11 |
Results: 11
Sexual activity as a trigger of myocardial infarction. A case-crossover analysis in the Stockholm Heart Epidemiology Programme (SHEEP)
Authors: Moller, J Ahlbom, A Hulting, J Diderichsen, F de Faire, U Reuterwall, C Hallqvist, J
Citation: J. Moller et al., Sexual activity as a trigger of myocardial infarction. A case-crossover analysis in the Stockholm Heart Epidemiology Programme (SHEEP), HEART, 86(4), 2001, pp. 387-390
Risk assessment in patients with acute myocardial infarction treated with thrombolytic therapy
Authors: Jensen-Urstad, M Samad, BA Jensen-Urstad, K Hulting, J Ruiz, H Bouvier, F Hojer, J
Citation: M. Jensen-urstad et al., Risk assessment in patients with acute myocardial infarction treated with thrombolytic therapy, J INTERN M, 249(6), 2001, pp. 527-537
Spontaneous delayed recovery of perfusion after thrombolyzed acute myocardial infarction: Is it predictable before discharge?
Authors: Samad, BA Hojer, J Bouvier, F Jensen-Urstad, K Frick, M Ruiz, H Hulting, J Jensen-Urstad, M
Citation: Ba. Samad et al., Spontaneous delayed recovery of perfusion after thrombolyzed acute myocardial infarction: Is it predictable before discharge?, J AM S ECHO, 14(9), 2001, pp. 902-909
Myocardial viability in patients with thrombolyzed myocardial infarction: Is it assessable by predischarge exercise electrocardiography test?
Authors: Samad, BA Jensen-Ustad, K Hulting, J Ruiz, H Hojer, J Bouvier, F Jensen-Urstad, M
Citation: Ba. Samad et al., Myocardial viability in patients with thrombolyzed myocardial infarction: Is it assessable by predischarge exercise electrocardiography test?, CLIN CARD, 24(1), 2001, pp. 21-25
Predicting in-hospital mortality in acute myocardial infarction: Impact ofthrombolytic therapy on APACHE II performance
Authors: Ludwigs, U Csatlos, M Hulting, J
Citation: U. Ludwigs et al., Predicting in-hospital mortality in acute myocardial infarction: Impact ofthrombolytic therapy on APACHE II performance, SC CARDIOVA, 34(4), 2000, pp. 371-376
Prognostic value of symptom limited versus low level exercise stress test before discharge in patients with myocardial infarction treated with thrombolytics
Authors: Jensen-Urstad, K Samad, BA Bouvier, F Hulting, J Hojer, J Ruiz, H Jensen-Urstad, M
Citation: K. Jensen-urstad et al., Prognostic value of symptom limited versus low level exercise stress test before discharge in patients with myocardial infarction treated with thrombolytics, HEART, 82(2), 1999, pp. 199-203
Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease
Authors: Lowbeer, C Ottosson-Seeberger, A Gustafsson, SA Norrman, R Hulting, J Gutierrez, A
Citation: C. Lowbeer et al., Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease, NEPH DIAL T, 14(8), 1999, pp. 1948-1955
Differential inhibition of thrombin activity and thrombin generation by a synthetic direct thrombin inhibitor (napsagatran, Ro 46-6240) and unfractionated heparin in patients with deep vein thrombosis
Authors: Bounameaux, H Ehringer, H Gast, A Hulting, J Rasche, H Rapold, HJ Reber, G Tschopp, TB
Citation: H. Bounameaux et al., Differential inhibition of thrombin activity and thrombin generation by a synthetic direct thrombin inhibitor (napsagatran, Ro 46-6240) and unfractionated heparin in patients with deep vein thrombosis, THROMB HAEM, 81(4), 1999, pp. 498-501
Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
Authors: Wallentin, L Swahn, E Kontny, F Husted, S Lagerqvist, B Stahle, E Nielsen, JD Dellborg, M Geiran, O Grande, P Hulting, J Kyst-Madsen, J Nordrehaug, JE Naslund, U Pilegaard, H Rollag, A Nielsen, TT Saetre, H Siegbahn, A Ohlin, H Arbeus, M Bylund, H Ekstrom, SL Eriksson, GP Geiran, O Holmgren, A Kellerth, T Kyst-Madsen, J Lindblom, D Lindvall, B Nordrehaug, J Pilegaard, H Radegran, K Sjogren, I Stenport, G Stahl, E Svane, B Svedjeholm, R Toftegaard-Nielsen, T Hassan, SY Naslund, U Persson, S Jacobsson, KA Thygesen, K von der Lippe, G Julian, D Bertrand, M Wedel, H Andren, B Diderholm, E Frostfeldt, G Jernberg, T Dellborg, M Abrahamsson, P Lindahl, B Jernberg, T Siegbahn, A Venge, P Swahn, E Janzon, M Logander, E Svensson, E Lindstrom, G Alsjo, G Gulin, M Setterberg, G Wikstrom, L Andersen, IM Seim, T
Citation: L. Wallentin et al., Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, LANCET, 354(9180), 1999, pp. 701-707
Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
Authors: Wallentin, L Swahn, E Kontny, F Husted, S Lagerqvist, B Stahle, E Nielsen, JD Dellborg, M Geiran, O Grande, P Hulting, J Kyst-Madsen, J Nordrehaug, JE Naslund, U Pilegaard, H Rollag, A Nielsen, TT Saetre, H Siegbahn, A Ohlin, H Lagerqvist, B Arbeus, M Bylund, H Ekstrom, L Eriksson, P Geiran, O Holmgren, A Kellerth, T Kyst-Madsen, J Lindblom, D Lindvall, B Nordrehaug, J Pilegaard, H Radegran, K Sjogren, I Stenport, G Stahl, E Svane, B Svedjeholm, R Toftegaard-Nielsen, T Hassan, SY Naslund, U Persson, S Jacobsson, KA Thygesen, K von der Lippe, G Julian, D Bertrand, M Wedel, H Andren, B Diderholm, E Frostfeldt, G Jernberg, T Dellborg, M Abrahamsson, P Lindahl, B Jernberg, T Siegbahn, A Venge, P Swahn, E Janzon, M Logander, E Svensson, E Lindstrom, G Alsjo, G Gulin, M Setterberg, G Wikstrom, L M-Andersen, I Seim, T
Citation: L. Wallentin et al., Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, LANCET, 354(9180), 1999, pp. 708-715
Reply to letter in September issue of AJC
Authors: Jensen-Urstad, K Bouvier, F Hojer, J Ruiz, H Hulting, J Samad, B Thorstrand, C Jensen-Urstad, M
Citation: K. Jensen-urstad et al., Reply to letter in September issue of AJC, AM J CARD, 83(1), 1999, pp. 141-141
Risultati: 1-11 |